Daniel C McFarland1, Rebecca M Saracino1, Andrew H Miller2, William Breitbart1, Barry Rosenfeld3, Christian Nelson1. 1. Department of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. 2. Department of Psychiatry & Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA. 3. Department of Psychology, Fordham University, Bronx, NY 10458, USA.
Abstract
Background: Lung cancer-related inflammation is associated with depression. Both elevated inflammation and depression are associated with worse survival. However, outcomes of patients with concomitant depression and elevated inflammation are not known. Materials & methods: Patients with metastatic lung cancer (n = 123) were evaluated for depression and inflammation. Kaplan-Meier plots and Cox proportional hazard models provided survival estimations. Results: Estimated survival was 515 days for the cohort and 323 days for patients with depression (hazard ratio: 1.12; 95% CI: 1.05-1.179), 356 days for patients with elevated inflammation (hazard ratio: 2.85, 95% CI: 1.856-4.388), and 307 days with both (χ2 = 12.546; p < 0.001]). Conclusion: Depression and inflammation are independently associated with inferior survival. Survival worsened by inflammation is mediated by depression-a treatable risk factor.
Background: Lung cancer-related inflammation is associated with depression. Both elevated inflammation and depression are associated with worse survival. However, outcomes of patients with concomitant depression and elevated inflammation are not known. Materials & methods: Patients with metastatic lung cancer (n = 123) were evaluated for depression and inflammation. Kaplan-Meier plots and Cox proportional hazard models provided survival estimations. Results: Estimated survival was 515 days for the cohort and 323 days for patients with depression (hazard ratio: 1.12; 95% CI: 1.05-1.179), 356 days for patients with elevated inflammation (hazard ratio: 2.85, 95% CI: 1.856-4.388), and 307 days with both (χ2 = 12.546; p < 0.001]). Conclusion: Depression and inflammation are independently associated with inferior survival. Survival worsened by inflammation is mediated by depression-a treatable risk factor.
Authors: Manish K Jha; Abu Minhajuddin; Bharathi S Gadad; Tracy Greer; Bruce Grannemann; Abigail Soyombo; Taryn L Mayes; A John Rush; Madhukar H Trivedi Journal: Psychoneuroendocrinology Date: 2017-01-24 Impact factor: 4.905
Authors: Oscar Arrieta; Laura P Angulo; Carolina Núñez-Valencia; Yuzmiren Dorantes-Gallareta; Eleazar O Macedo; Dulce Martínez-López; Salvador Alvarado; José-Francisco Corona-Cruz; Luis F Oñate-Ocaña Journal: Ann Surg Oncol Date: 2012-12-22 Impact factor: 5.344
Authors: Lorenzo Cohen; Steven W Cole; Anil K Sood; Sarah Prinsloo; Clemens Kirschbaum; Jesusa M G Arevalo; Nicholas B Jennings; Shellie Scott; Luis Vence; Qi Wei; Diane Kentor; Laszlo Radvanyi; Nizar Tannir; Eric Jonasch; Pheroze Tamboli; Louis Pisters Journal: PLoS One Date: 2012-08-01 Impact factor: 3.240
Authors: Daniel C McFarland; Meredith Doherty; Thomas M Atkinson; Robin O'Hanlon; William Breitbart; Christian J Nelson; Andrew H Miller Journal: Cancer Date: 2022-04-13 Impact factor: 6.921
Authors: Oscar Fraile-Martinez; Miguel A Alvarez-Mon; Cielo Garcia-Montero; Leonel Pekarek; Luis G Guijarro; Guillermo Lahera; Miguel A Saez; Jorge Monserrat; Domitila Motogo; Javier Quintero; Melchor Alvarez-Mon; Miguel A Ortega Journal: Front Oncol Date: 2022-09-16 Impact factor: 5.738